Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Solas

Showing results (41-50 of 121) with videos related to

Pageof 13
Sort By:
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|January 14, 2020
A simple and rapid liquid chromatography-mass spectrometry method to assay cabozantinib in plasma: Application to therapeutic drug monitoring in patients with renal cell carcinomaFlorent Ferrer, Caroline Solas, Madeline Giocanti, et al.
European Journal of Cancer (Oxford, England : 1990)|July 2, 2020
Anticancer drugs and COVID-19 antiviral treatments in patients with cancer: What can we safely use?Paul Gougis, Charlotte Fenioux, Christian Funck-Brentano, et al.
International Journal of Antimicrobial Agents|August 11, 2020
Effects of Hydroxychloroquine on Covid-19 in Intensive Care Unit Patients: Preliminary ResultsAlexandre Lopez, Gary Duclos, Bruno Pastene, et al.
Annals of Hepatology|June 14, 2014
Rhabdomyolysis in a hepatitis C virus infected patient treated with telaprevir and simvastatinClara T M M de Kanter, Matthijs van Luin, Caroline Solas, et al.
The Journal of Antimicrobial Chemotherapy|July 31, 2025
Leakage of cabotegravir and rilpivirine in HIV patients receiving long-acting injectable antiretroviral therapySamir Benkouiten, Hélène Laroche, Véronique Obry-Roguet, et al.
Cancer Chemotherapy and Pharmacology|October 5, 2011
Impact of plasma and intracellular exposure and CYP3A4, CYP3A5, and ABCB1 genetic polymorphisms on vincristine-induced neurotoxicityRomain Guilhaumou, Caroline Solas, Veronique Bourgarel-Rey, et al.
Toxics|February 24, 2022
Determination of Prenatal Substance Exposure Using Meconium and Orbitrap Mass SpectrometryAtakan Hernandez, Valerie Lacroze, Natalia Doudka, et al.
Bulletin Du Cancer|August 28, 2021
Do people living with HIV face more secondary cancers than general population: From the French CANCERVIH networkMarianne Veyri, Armelle Lavolé, Sylvain Choquet, et al.
Therapeutic Drug Monitoring|September 23, 2008
Population pharmacokinetics of atazanavir in human immunodeficiency virus-infected patientsCaroline Solas, Marie-Claude Gagnieu, Isabelle Ravaux, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 28, 2002
Pharmacokinetic interaction between lopinavir/r and amprenavir in salvage therapyStéphanie Basso, Caroline Solas, Anne-Marie Quinson, et al.
Pageof 13

Showing results (41-50 of 121) with videos related to

Sort By:
Pageof 13
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|January 14, 2020
A simple and rapid liquid chromatography-mass spectrometry method to assay cabozantinib in plasma: Application to therapeutic drug monitoring in patients with renal cell carcinomaFlorent Ferrer, Caroline Solas, Madeline Giocanti, et al.
European Journal of Cancer (Oxford, England : 1990)|July 2, 2020
Anticancer drugs and COVID-19 antiviral treatments in patients with cancer: What can we safely use?Paul Gougis, Charlotte Fenioux, Christian Funck-Brentano, et al.
International Journal of Antimicrobial Agents|August 11, 2020
Effects of Hydroxychloroquine on Covid-19 in Intensive Care Unit Patients: Preliminary ResultsAlexandre Lopez, Gary Duclos, Bruno Pastene, et al.
Annals of Hepatology|June 14, 2014
Rhabdomyolysis in a hepatitis C virus infected patient treated with telaprevir and simvastatinClara T M M de Kanter, Matthijs van Luin, Caroline Solas, et al.
The Journal of Antimicrobial Chemotherapy|July 31, 2025
Leakage of cabotegravir and rilpivirine in HIV patients receiving long-acting injectable antiretroviral therapySamir Benkouiten, Hélène Laroche, Véronique Obry-Roguet, et al.
Cancer Chemotherapy and Pharmacology|October 5, 2011
Impact of plasma and intracellular exposure and CYP3A4, CYP3A5, and ABCB1 genetic polymorphisms on vincristine-induced neurotoxicityRomain Guilhaumou, Caroline Solas, Veronique Bourgarel-Rey, et al.
Toxics|February 24, 2022
Determination of Prenatal Substance Exposure Using Meconium and Orbitrap Mass SpectrometryAtakan Hernandez, Valerie Lacroze, Natalia Doudka, et al.
Bulletin Du Cancer|August 28, 2021
Do people living with HIV face more secondary cancers than general population: From the French CANCERVIH networkMarianne Veyri, Armelle Lavolé, Sylvain Choquet, et al.
Therapeutic Drug Monitoring|September 23, 2008
Population pharmacokinetics of atazanavir in human immunodeficiency virus-infected patientsCaroline Solas, Marie-Claude Gagnieu, Isabelle Ravaux, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 28, 2002
Pharmacokinetic interaction between lopinavir/r and amprenavir in salvage therapyStéphanie Basso, Caroline Solas, Anne-Marie Quinson, et al.
Pageof 13